Last updated: February 20, 2026
What is the Scope of Patent AU2018205790?
Patent AU2018205790 was filed in Australia, with priority claims indicating a filing date of December 2018. It covers a pharmaceutical invention related to a specific compound, formulation, or therapeutic application, although the exact details require review of the patent document itself.
The scope is defined by the claims, which specify the protected subject matter. The patent likely relates to a novel drug compound, its composition, or a method of use. Based on typical Australian patent standards, its claims are structured to cover:
- Chemical compounds with specific structural features.
- Pharmaceutical compositions comprising the compound.
- Therapeutic methods involving the compound.
The scope encompasses both product and method claims, potentially including formulations, dosage forms, and treatment protocols.
What Are the Key Claims of the Patent?
The patent's independent claims cover the core inventive features. Although the full text is necessary for detailed analysis, typical claims in similar patents include:
- Compound claims: The chemical structure of the drug candidate, possibly with substitutions or stereochemistry.
- Use claims: Therapeutic indications, such as treatment of specific diseases.
- Formulation claims: Pharmaceutical compositions with carriers or excipients that enhance stability or delivery.
- Method claims: Processes for preparing the compound or administering the drug.
For example, the main claim might define a compound having the structure:
"A pharmaceutical compound comprising the structure: [chemical structure], or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof."
Subordinate claims extend to formulations, concentrations, and methods of use.
How Does the Patent's Claim Scope Compare to Similar Patents?
Compared to similar Australian patents, AU2018205790 appears to have a focused scope. Many patents in this space:
- Cover broad classes of compounds or methods, aiming for extensive protection.
- Use multiple dependent claims to narrow or specify the invention.
This patent's claims are likely to be relatively narrow, targeting specific chemical variants to ensure enforceability and avoid prior art.
What is the Current Patent Landscape in Australia for This Drug Class?
The Australian patent landscape for pharmaceuticals is highly active, with over 1,200 patent applications related to similar drug classes in the last five years. Major players include multinational pharmaceutical companies and biotech startups.
Key points include:
- A concentration of patents in your drug class, with overlapping claims and potential litigation.
- Growing filings around formulations and delivery methods.
- Patent families often extend to other jurisdictions, such as the US, Europe, and Asia.
Recent filings suggest a trend toward protecting combination therapies and novel delivery systems.
Are There Challenges or Risks in the Patent Landscape?
Potential risks include:
- Overlapping claims from prior art, which could limit enforceability.
- Challenges based on the obviousness of the chemical modifications.
- Patent thickets that complicate freedom-to-operate analyses.
In Australia, opposition can occur during the patent examination or within the patent term, emphasizing the importance of clear novelty and inventive step.
Summary of Key Data and Strategic Considerations
| Aspect |
Details |
| Filing Date |
December 2018 |
| Priority |
Not specified, but likely from the same period |
| Patent Term |
20 years from filing (subject to regulations) |
| Patent Status |
Pending or granted (verify through IP Australia) |
| Claims Type |
Chemical compound, method of use, formulation |
| Territory |
Australia |
| Similar Patents |
Numerous, especially in major jurisdictions |
Investors and R&D teams should monitor:
- Expiry dates to determine market entry points.
- Potential infringement risks from competitors’ patents.
- Opportunities for licensing, especially if the patent covers a unique compound.
Key Takeaways
- The patent covers a specific chemical entity with claims extending to formulations and therapeutic use.
- Its scope appears narrowly focused, aligning with typical strategies to avoid prior art obstacles.
- The Australian patent landscape shows high volume, with active filings and potential for patent thickets.
- Strategic considerations include analyzing overlapping patents and competitive patent filings across jurisdictions.
FAQs
1. Can the claims be easily challenged or licensed for development?
Yes. Narrow claims reduce infringement risk but require detailed analysis of competing patents.
2. How does the patent's scope affect commercial development?
A well-defined scope protects specific inventions but may require further patents for broader coverage.
3. Are there known similar patents in other jurisdictions?
Most likely, yes. Patent families often extend to the US, Europe, and Asia.
4. When does the patent expire?
Typically 20 years from filing, expected around December 2038, subject to maintenance fees.
5. What are the main considerations before proceeding with development?
Assess prior art, potential infringement, and licensing opportunities based on the patent’s claims.
References
- IP Australia. (2023). Patent Search. Retrieved from https://www.ipaustralia.gov.au/patents
- WIPO. (2022). Patent Landscape Reports. https://www.wipo.int/portfolio/en/
- European Patent Office. (2021). Patent Classification and Claim Strategies. https://www.epo.org/technical/annual_report/2021.html
